Skip to content
healthcare.dev

Terazosin Hydrochloride

NDC 69292-202, Terazosin Hydrochloride, capsule, from Amici Pharma, Inc..

Product NDC
69292-202
Status
Listed
Labeler
Amici Pharma, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074823
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69292-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
69292-202-0169292020201100 CAPSULE in 1 BOTTLE (69292-202-01)
69292-202-10692920202101000 CAPSULE in 1 BOTTLE (69292-202-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4007dbd3-e850-43e7-8a56-8735e31063cd

Use it

Look up 69292-202 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69292-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69292-202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.